This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1991 Mar;63(3):328-32.

doi: 10.1038/bjc.1991.78.

c-erbB-2 oncogene as a prognostic marker in breast cancer

PMID: 1672251
PMCID: PMC1971858
DOI: 10.1038/bjc.1991.78

Free PMC article

Review

c-erbB-2 oncogene as a prognostic marker in breast cancer

T J Perren. Br J Cancer. 1991 Mar.

Free PMC article

. 1991 Mar;63(3):328-32.

doi: 10.1038/bjc.1991.78.

Author

PMID: 1672251
PMCID: PMC1971858
DOI: 10.1038/bjc.1991.78

No abstract available

PubMed Disclaimer

Similar articles

Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
Nagai MA, Marques LA, Torloni H, Brentani MM. Nagai MA, et al. Oncology. 1993 Nov-Dec;50(6):412-7. doi: 10.1159/000227221. Oncology. 1993. PMID: 7901824
The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer.
Dean CJ, Allan S, Eccles S, McFarlane C, Styles J, Valeri M, Sandle J, Bakir A, Sacks N. Dean CJ, et al. Year Immunol. 1993;7:182-92. Year Immunol. 1993. PMID: 8103950 Clinical Trial. No abstract available.
Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance.
Blin N, Kardaś I, Welter C, Ryś J, Niezabitowski A, Limon J, Seitz G. Blin N, et al. Oncology. 1993 Nov-Dec;50(6):408-11. doi: 10.1159/000227220. Oncology. 1993. PMID: 7901823
Neu (C-erbB-2) oncogene in breast cancer and its possible association with the risk of distant metastases. A retrospective study and review of literature.
Makar AP, Desmedt EJ, De Potter CR, Vanderheyden JS, Schatteman EA. Makar AP, et al. Acta Oncol. 1990;29(7):931-4. doi: 10.3109/02841869009096392. Acta Oncol. 1990. PMID: 1979748 Review.
Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
Singleton TP, Strickler JG. Singleton TP, et al. Pathol Annu. 1992;27 Pt 1:165-90. Pathol Annu. 1992. PMID: 1346551 Review.

See all similar articles

Cited by

The prognostic value of c-erbB2 in primary breast carcinomas: a study on 942 cases.
Quénel N, Wafflart J, Bonichon F, de Mascarel I, Trojani M, Durand M, Avril A, Coindre JM. Quénel N, et al. Breast Cancer Res Treat. 1995 Sep;35(3):283-91. doi: 10.1007/BF00665980. Breast Cancer Res Treat. 1995. PMID: 7579499
Bimodal gene expression patterns in breast cancer.
Bessarabova M, Kirillov E, Shi W, Bugrim A, Nikolsky Y, Nikolskaya T. Bessarabova M, et al. BMC Genomics. 2010 Feb 10;11 Suppl 1(Suppl 1):S8. doi: 10.1186/1471-2164-11-S1-S8. BMC Genomics. 2010. PMID: 20158879 Free PMC article.
Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.
Rehman S, Crow J, Revell PA. Rehman S, et al. Pathol Oncol Res. 2000;6(4):256-63. doi: 10.1007/BF03187328. Pathol Oncol Res. 2000. PMID: 11173657
Expression of the ERBB3 gene product in breast cancer.
Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC. Lemoine NR, et al. Br J Cancer. 1992 Dec;66(6):1116-21. doi: 10.1038/bjc.1992.420. Br J Cancer. 1992. PMID: 1333787 Free PMC article.
Significance of immunohistochemical c-ErbB-2 product localisation pattern for prognosis in human breast cancer.
Aziz SA, Pervez S, Khan S, Kayani N, Azam SI, Rahbar MH. Aziz SA, et al. Pathol Oncol Res. 2001;7(3):190-6. doi: 10.1007/BF03032348. Pathol Oncol Res. 2001. PMID: 11692145

See all "Cited by" articles

References

1. Cancer Res. 1990 Jul 15;50(14):4332-7 - PubMed
1. J Clin Oncol. 1990 Jan;8(1):103-12 - PubMed
1. N Engl J Med. 1990 Feb 1;322(5):297-302 - PubMed
1. Br J Cancer. 1982 Mar;45(3):361-6 - PubMed
1. Br J Cancer. 1991 Mar;63(3):434-8 - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal